Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (9)

2023

  1. Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 12, pp. 985-995

2021

  1. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274

2020

  1. Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1034-1051

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2016

  1. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 308-315

2012

  1. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study

    Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5

2011

  1. Factors associated with a higher prevalence of work disability among asthmatic patients

    Journal of Asthma, Vol. 48, Núm. 2, pp. 194-199

2010

  1. Factors associated with asthma control in primary care patients: The CHAS study

    Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363

2009

  1. Inflammatory activation and left ventricular mass in essential hypertension

    American Journal of Hypertension, Vol. 22, Núm. 4, pp. 444-450